Orphandrugs are either drug or biologic products used to treat diseases or conditions affecting fewer than 200,000 people in the United States.
孤儿药物包括药物或者生物制品，用于治疗疾病，并且在美国发病人数少于20万人。
2
It is recommended to perfect orphandrugs medical insurance access standard, introduce risk-sharing mechanism and standardize the use of orphandrugs and reimbursement in China.
建议完善我国罕用药医保遴选标准，引入风险共担机制及规范罕用药的使用和报销。
3
The European orphan diseases market grapples with numerous challenges. Of these, the most serious are the lack of awareness, poor diagnosis and limited accessibility of orphandrugs.